%0 Journal Article %T Case Report: Oxaliplatin-Induced Immune-Mediated Thrombocytopenia %A Caroline Piatek %A Elizabeth Pan %A Eric Hsieh %J Archive of "Case Reports in Oncology". %D 2018 %R 10.1159/000495032 %X Thrombocytopenia is a frequent complication of cancer may be due to a variety of causes including malignancy itself, acute disease processes, or cancer therapy. Systemic cancer therapy is the most common cause of thrombocytopenia in cancer patients observed nearly two-thirds of patients with solid tumors. Thrombocytopenia with traditional chemotherapy agents is most frequently the result of megakaryocyte cytotoxicity. Oxaliplatin is a platinum derivative commonly used in gastrointestinal malignancies and is associated with drug-induced immune thrombocytopenia %K Adenocarcinoma %K Oxaliplatin %K Thrombocytopenia %U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341312/